维普中文期刊产品整合服务
33篇 您的检索式:作者名="Hunninghake DB"
    题名 作者 年代 出处 被引量
1A dose-ranging study of a new,once-daily,dual-component drug product containing niacin extended-release and lovastatin显示文摘Hunninghake DB McGovern ME Koren M 2003Clin Cardiol2003,26,3:1
2Safety of rosuvastatin显示文摘Shepherd J Hunninghake DB Stein EA 2004Am J Cardiol2004,94,7:1
3Long-term treatment of hypereholesterolemia with dietary fiber显示文摘Hunninghake DB Miller VT LaRosa JC 1994Am J Med1994,97,6:1
4A dose-ranging study of a new, once-daily, dual-component drug product containing niacin extended-release and lovastatin 显示文摘Hunninghake DB McGovern ME Koren M 2003Clin Cardiol2003,26,3:1
5Guidelines for low- ering lipids to reduce coronary artery disease risk: a comparison of rosuvastatin with atorvastatin, pravastatin, and simvastatin for a- chieving lipid-lowering goals, 2003显示文摘Shepherd J Hunninghake DB Barter P 2004Atheroscler Suppl2004,5,3:1
6The efficacy of intensive dietary therapy alone or combined with lovastatin in outpatients with hypercholesterolemia显示文摘Hunninghake DB Stein EA Dujovne CA 1993N Engl J Med1993,328,:1
7Effects of rosuvastat in versus atorvastatin,simvastatin,and pravastatin on non-high- density lipoprotein cholesterol apolipoproteins,and lipid ratios in patients with hypercholesterolemia: additional results from the STELLAR trial显示文摘Jones PH Hunninghake DB Ferdinand KC 2004ClinTher2004,26,9:1
8Cardiovascular disease in chronic obstructive pulmonary disease 显示文摘Hunninghake DB 2005Proc Am Thorac Soc2005,2,1:1
9Comparative effeets of simvastatin and atorvastatin in hypercholesterolemic patients with characteristics of metabolic syndrome 显示文摘Hunninghake DB Ballantyne CM Maccubbin DL 2003Clin Ther2003,25,6:1
10Cardiovascular disease in chronic obstructive pulmonary disease显示文摘Hunninghake DB 2005Proc Am Thorac Soc2005,2,1:1
11Effect of estrogen plus progestin on risk for biliary tract surgery in postmenopausal women with coronary artery disease:The Heart and Estrogen/progestin Replacement Study显示文摘Simon JA Hunninghake DB Agarwal SK 2001Ann Int Med2001,135,7:1
12A dose ranging study of a new, once- daily, dual - component drug product containing niacin extended- release and lovastatin 显示文摘Hunninghake DB McGovern ME Koren M 2003Clin Cardiol2003,6,3:1
13Clinical outcomes in managed - care patients with coronary heart disease treated aggressively in lipid-lowering disease management clinics: The Alliance study 显示文摘Koren MJ Hunninghake DB 2004J Am Coll Cardiol2004,44,:1
14Efect of niacin on lipidand lipoprotein levels and glycemic control in patients with diabetesand peripheral arterial disease: the ADMIT study,a randomized trial显示文摘Elam MB Hunninghake DB Davis KB 2000JAMA2000,284,10:1
15The efficacy of intensive dietary therapy alone or combined with lovastatin in out- patients with hypercholesterolemia显示文摘Hunninghake DB Stein EA Dujovne CA 1993N Engl J Med1993,328,17:1
16Effects of ro- suvastatin versus atorvastatin, simvastatin, and pravastatin on non - high - density lipoprotein cholesterol, apolipoproteins, and lipid ratios in patients with hypercholesterole - mia; additional results from the STELLAR trial显示文摘Jones PH Hunninghake DB Ferdinand KC 2004Clin Ther2004,26,9:1
17A dose-ranging study of a new,once-daily,dual-component drug product containing niacin extended-release and lovastatin显示文摘Hunninghake DB McGovern ME Koren M 2003Clin Cardiol2003,26,3:1
18Clinical efficacy of cerivastatin: phase Ⅱ a doseranging and dose- scheduling studies 显示文摘Hunninghake DB 1998Am J Cardiol1998,82,4:1
19Rosuvastatin imp roves the atherogenic and atherop rotective lip id p rofiles in patients with hypertriglyceridemia显示文摘Hunninghake DB Stein EA Bays HE 2004Coron Artely Dis2004,15,2:1
20Cardiovascular disease in chronic obstructive pul- monary Disease 显示文摘Hunninghake DB 2005Proc Am Thorac Soc2005,2,1:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费